Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma

NACompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

January 1, 2021

Study Completion Date

August 10, 2021

Conditions
Hepatocellular CarcinomaEsophagogastric Varices
Interventions
PROCEDURE

transarterial chemoembolization combined with endoscopic therapy

TACE: The tip of the catheter was advanced into tumor-feeding artery based on the tumor location and size. 5-Fu was injected. Then the chemolipiodolization was performed, using oxaliplatin, epirubicin and lipiodol. If stagnant flow did not realized, then injected pure lipiodol. If the tumor-feeding artery still cannot be completely embolized, several absorbable gelatin sponge particles would be injected. Endoscopic therapy: After the site of esophageal varices was identified by the gastroscopy, spiral ligation using the EVL device (COOK, MBL-6-F) was performed and ensure the varices were fully inhaled, 1-3 rubber bands were used totally. After EVL, water was sprayed to the ligation sites to check for bleeding. If gastric varices were found, EIS was performed using the 'sandwich method' of hypertonic glucose-tissue adhesive-normal saline. Make sure the needle entered the varieose vein before inject drugs, and repeated the injection if necessary.

Trial Locations (1)

250012

Qilu Hospital , Shandong University, Jinan

All Listed Sponsors
lead

Qilu Hospital of Shandong University

OTHER

NCT05017922 - Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter